Related Experiment Video
Updated: Jun 1, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis
Michelle Monje1, Jörg Dietrich
1Department of Neurology, Division of Child Neurology, Stanford University Medical Center, 750 Welch Road, Suite 317, Palo Alto, CA 94304, USA. mmonje@stanford.edu
Abstract:
Cancer therapies frequently result in a spectrum of neurocognitive deficits that include impaired learning, memory, attention and speed of information processing. Damage to dynamic neural progenitor cell populations in the brain are emerging as important etiologic factors. Radiation and chemotherapy-induced damage to neural progenitor populations responsible for adult hippocampal neurogenesis and for maintenance of subcortical white matter integrity are now believed to play major roles in the neurocognitive impairment many cancer survivors experience.
Insights
Cancer treatments can harm brain stem cells, leading to cognitive problems like memory loss and attention deficits in survivors. This damage affects learning and information processing speed.
Area of Science:
- Neuroscience
- Oncology
- Cancer Survivorship
Background:
- Cancer therapies often cause neurocognitive deficits affecting learning, memory, attention, and processing speed.
- Damage to neural progenitor cells is a key factor in these deficits.
Purpose of the Study:
- To examine the role of damage to neural progenitor cells in cancer-related neurocognitive impairment.
- To understand the impact of radiation and chemotherapy on brain progenitor populations.
Main Methods:
- Investigated the effects of cancer treatments on neural progenitor cell populations.
- Focused on progenitor cells in the hippocampus and subcortical white matter.
Main Results:
- Radiation and chemotherapy damage neural progenitor cells.
- This damage impacts adult hippocampal neurogenesis and white matter integrity.
Conclusions:
- Damage to neural progenitor cells is a significant cause of neurocognitive deficits in cancer survivors.
- Therapeutic strategies targeting these progenitor cells may mitigate cognitive impairment.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cognitive Development During Adulthood
Neurogenesis and Regeneration of Nervous Tissue
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

